Ardelyx (ARDX)

Ardelyx (ARDX) Stock Price & Analysis


ARDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.49 - $5.13
Previous Close$3.27
Average Volume (3M)7.50M
Market Cap
Enterprise Value$606.61M
Total Cash (Recent Filing)$130.37M
Total Debt (Recent Filing)$35.69M
Price to Earnings (P/E)-8.2
Aug 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding214,462,429
10 Day Avg. Volume7,023,129
30 Day Avg. Volume7,503,468
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)6.25
Price to Sales (P/S)61.69
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.62
Enterprise Value/Gross Profit12.63
Enterprise Value/Ebitda-8.36
Price Target Upside121.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Ardelyx’s price range in the past 12 months?
Ardelyx lowest stock price was $0.49 and its highest was $5.13 in the past 12 months.
    What is Ardelyx’s market cap?
    Currently, no data Available
    When is Ardelyx’s upcoming earnings report date?
    Ardelyx’s upcoming earnings report date is Aug 11, 2023 which is in 75 days.
      How were Ardelyx’s earnings last quarter?
      Ardelyx released its earnings results on May 03, 2023. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.101 by -$0.029.
        Is Ardelyx overvalued?
        According to Wall Street analysts Ardelyx’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ardelyx pay dividends?
          Ardelyx does not currently pay dividends.
          What is Ardelyx’s EPS estimate?
          Ardelyx’s EPS estimate is -$0.11.
            How many shares outstanding does Ardelyx have?
            Ardelyx has 214,462,430 shares outstanding.
              What happened to Ardelyx’s price movement after its last earnings report?
              Ardelyx reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.101. Following the earnings report the stock price went up 0.427%.
                Which hedge fund is a major shareholder of Ardelyx?
                Among the largest hedge funds holding Ardelyx’s share is Woodline Partners LP. It holds Ardelyx’s shares valued at 5M.


                  Ardelyx Stock Smart Score

                  The Ardelyx stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.


                  Top 5 ETFs holding ARDX

                  Market Value
                  Smart Score
                  Invesco DWA Healthcare Momentum ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold ARDX. The ETFs are listed according to market value of ARDX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  PepGen Inc.
                  Kinnate Biopharma
                  MiMedx Group
                  Organogenesis Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis